Table 2.
Patient characteristics at baseline, 6 and 12 months follow-up.*
| Variables | Baseline (n=163) |
6 months (n=83) |
12 months (n=57) |
p-Value |
|---|---|---|---|---|
| Sex, n (%) | ||||
| Female | 53 (32%) | 23 (28%) | 18 (32%) | 0.74 |
| Male | 110 (68%) | 60 (72%) | 39 (68%) | 0.74 |
| Age (years), mean (±std) | 64 (12) | 62 (12) | 61 (10) | 0.16 |
| Cancer site, n (%) | ||||
| Colon | 78 (48%) | 37 (45%) | 22 (39%) | 0.48 |
| Rectum | 85 (52%) | 46 (55%) | 35 (61%) | 0.48 |
| Cancer stage, n (%) | ||||
| I/II | 76 (47%) | 36 (43%) | 32 (56%) | 0.31 |
| III/IV | 87 (53%) | 47 (57%) | 25 (44%) | 0.31 |
| Parameters of energy balance, mean (±std) | ||||
| BMI (kg/m2) | 26.6 (±4.0) | 25.3 (±3.9) | 26.5 (±3.9) | 0.26 |
| METs (hours/week) | 12.3 (±16.8) | 10.3 (±14.8) | 12.2 (±15.9) | 0.63 |
| Adipose tissue area (cm2), mean (±std) | ||||
| Dorsal muscles L3/L4 | 30.1 (±14.5) | 31.3 (±14.5) | 31.6 (±14.4) | 0.87 |
| Dorsal muscles L4/L5 | 23.7 (±10.4) | 26.0 (±11.7) | 25.0 (±11.8) | 0.58 |
| Psoas muscles L3/L4 | 16.3 (±6.9) | 17.9 (±6.9) | 17.3 (±5.8) | 0.42 |
| Psoas muscles L4/L5 | 19.1 (±7.7) | 22.1 (±13.6) | 21.8 (±13.9) | 0.31 |
| Abdominal muscles L3/L4s | 32.0 (±14.7) | 34.7 (±14.0) | 48.4 (±1.1) | 0.31 |
| Abdominal muscles L4/L5 | 26.3 (±9.2) | 29.0 (±8.2) | 32.3 (±2.3) | 0.55 |
*
Sample availability for the urinary metabolomics analysis of study population.